P461
The role of edema and demyelination in chronic T1 black holes: a quantitative magnetization transfer study.Multi-parametric MR assessment of T(1) black holes in multiple sclerosis : evidence that myelin loss is not greater in hypointense versus isointense T(1) lesions.Lessons from a BACE1 inhibitor trial: off-site but not off base.Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.Late onset adrenoleukodystrophy: A review related clinical case reportSemaphorin4A causes loss of mature oligodendrocytes and demyelination in vivoThe Contribution of Various MRI Parameters to Clinical and Cognitive Disability in Multiple SclerosisFacets of Theiler's Murine Encephalomyelitis Virus-Induced Diseases: An UpdateAdvanced imaging findings in progressive solitary sclerosis: a single lesion or a global disease?Lysophosphatidic acid receptor type 2 activation contributes to secondary damage after spinal cord injury in miceInhibiting Bone Morphogenetic Protein 4 Type I Receptor Signaling Promotes Remyelination by Potentiating Oligodendrocyte DifferentiationElevated lipid peaks during the recovery phase of Baló's concentric sclerosis: A case reportVenlafaxine Improves the Cognitive Impairment and Depression-Like Behaviors in a Cuprizone Mouse Model by Alleviating Demyelination and Neuroinflammation in the BrainMyelin Damage in Diffuse Axonal InjuryMyelinoclastic diffuse sclerosis (Schilder's disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar puncturesInterferon-Stimulated Genes-Mediators of the Innate Immune Response during Canine Distemper Virus InfectionMicroglial SIRPα regulates the emergence of CD11c microglia and demyelination damage in white matterMechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple SclerosisRegulatory effects of hemp seed/evening primrose oil supplement in comparison with rapamycin on the expression of the mammalian target of and genes in experimental autoimmune encephalomyelitismiR-381 Attenuates Peripheral Neuropathic Phenotype Caused by Overexpression of PMP22Study Evaluating the Safety of Myeliviz Myelin-Targeting PET Agent
P921
Q30981183-c12b6e2a-47d4-318f-efd9-9720bf47a9ecQ31133004-238E53D4-1F77-4F3D-8895-7ED0DF48FC4CQ34381433-5BA1C6FA-2394-4057-AAB1-0B9FAEBF11ADQ35495245-6A2F3FB1-C0A6-4F52-BD1E-049968380E99Q60912571-AF45C693-1350-40E9-9459-56674F23F508Q61797424-AD58ECC1-DB23-4921-A477-D67C7D2794CCQ61811101-C8EBC2C3-22FD-4687-B8F8-E9C5C03FB670Q61812460-7D4BDC6F-D6EC-4C89-BDF4-A8588E016DD7Q61815497-A4FB66AB-BA3C-4B68-971B-9AE7CE133E1CQ63915705-D013C1B8-93AE-4BB3-971B-1790C59C8EA9Q64055987-5BFE3FB7-1A34-4D67-8881-FA9C9906D2BAQ64062838-4527382A-753F-4538-8F8D-EE79D5B5EA5CQ64072027-59F27EC7-CF09-499C-8E31-47499AB85E61Q64075440-7292C93C-4571-45F9-9D4B-5234B1821434Q64089583-70E5C845-7A5E-4460-BE9F-5B8C07763EE5Q64093573-E20BEAB3-055C-4E29-ABFB-7B20EB9CEF5EQ64117579-3AC47336-A71D-43A3-A578-85A64374C664Q64229784-B2FF46FB-1625-4DE9-BFD8-94D55F93F1F6Q64246513-2FB98FBC-6D0D-439C-8887-CB8278792ADEQ64265938-A2D42993-EB5B-4A09-A768-F0E86384865AQ89507126-6BC2FED5-BD52-4162-9E22-347ECE4F38D9
P921
description
proceso patológico en el cual se daña la capa de mielina de las fibras nerviosa
@es
name
Demyelinisatie
@nl
Demyelinisation
@de
Desmielinizacion
@oc
Desmielinización
@gl
demielinizacja
@pl
demyelination
@en
demyelinisering
@nn
desmielinització
@ca
desmielinización
@es
desmielinização
@pt
type
label
Demyelinisatie
@nl
Demyelinisation
@de
Desmielinizacion
@oc
Desmielinización
@gl
demielinizacja
@pl
demyelination
@en
demyelinisering
@nn
desmielinització
@ca
desmielinización
@es
desmielinização
@pt
altLabel
Demyelinisierung
@de
Entmarkung
@de
desmielinacion
@es
desmielinación
@es
desmielinizacion
@es
زوال الميالين
@ar
زوال النخاعين
@ar
نزع الميالين
@ar
prefLabel
Demyelinisatie
@nl
Demyelinisation
@de
Desmielinizacion
@oc
Desmielinización
@gl
demielinizacja
@pl
demyelination
@en
demyelinisering
@nn
desmielinització
@ca
desmielinización
@es
desmielinização
@pt
P3219
demyelinisations
P461
P5082
demyelinisering